Diversified Royalty Corp. (the "Corporation" or "DIV") is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of January 1, 2026 to ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback